Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-06-15

Clinical Trial Update: The Efficacy and Safety of Chlorhexidine Gluconate Chip (Periochip®) in Therapy of Symptoms in Patients With Peri-implantitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating chlorhexidine gluconate chip (Periochip) for peri-implantitis; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PerioChip (chlorhexidine gluconate chip)

Snippet

Sponsor: Dexcel Pharma Technologies Ltd. | Conditions: Peri-implantitis | Phase 2 | Status: COMPLETED | Results posted: 2021-06-15